Angelina Jolie’s decision to reveal her mastectomy scars in a December 2025 feature for Time France and again in her February 2026 conversation with France Inter did not come across as a dramatic celebrity moment. It felt like a person stepping forward to reclaim a chapter of her life. When she called those scars her survival markers, it sounded like someone speaking from experience and from a place of truth.
She explained that she had always been more drawn to the stories people carry in their bodies than to any idea of a perfect life without marks. And when she said her scars represent a choice she made so she could remain alive for her children as long as possible, there was a deep sense of gratitude behind her words.
Gratitude for access. Gratitude for options. Gratitude for the ability to make a medical decision that many women never get the chance to consider.
View this post on Instagram
But once her reflections sink in, her story exposes something bigger. Jolie’s experience reveals a very real gap in preventive breast cancer care in the United States. Her procedure involved advanced techniques that are not available to everyone, even though federal laws technically support coverage for women who face a high risk.
The Details of Jolie’s Surgical Journey
In her well-known 2013 New York Times piece titled “My Medical Choice,” Jolie explained that her entire journey began with a procedure called a nipple delay. This took place on February 2 of that year.
During this procedure, the surgeon partially lifts the nipple and areola away from the tissue beneath so the body can form new blood routes. This lowers the chance of the nipple tissue dying during the later mastectomy and increases the odds of preserving both appearance and sensation.
It is a real technique, but it is not routine for every woman. It is usually reserved for those who may face a higher risk based on anatomy, past surgeries, or lifestyle factors. Many women never need this stage at all. They go straight to a single stage nipple sparing mastectomy and do very well. Jolie, however, had access to a specialist team that could design the safest and most effective plan for her body.
Two weeks after that first step, she underwent the main operation. It was a bilateral nipple sparing mastectomy with immediate reconstruction. Tissue expanders were placed at that point and later replaced with implants. It was a staged and carefully planned process that required skill, coordination, and experience.
And this is where the inequality becomes visible. Many women simply do not have access to this level of surgical expertise.
Insurance Coverage vs. Real-World Access
Federal law, through the Women’s Health and Cancer Rights Act of 1998, requires most insurance plans to cover reconstruction after mastectomy. This includes cases where the surgery is preventive for women with a very high risk, such as those with BRCA mutations.
The law covers reconstruction on both sides, procedures for symmetry, prostheses, and treatment for complications, including lymphedema. But coverage alone does not solve everything. It does not create more skilled surgeons. It does not change the fact that some women live far from specialists. It does not erase waiting lists or out-of-pocket costs that appear even within insurance plans.
Even though nipple delay is usually approved when it is medically necessary, it adds an extra appointment that some women cannot easily manage because of cost, distance, or personal responsibilities.
The Angelina Jolie Effect on Testing and Surgery Rates
Still, Jolie’s very open decision to tell her story had a powerful effect. Her announcement sparked a global rise in BRCA testing, a trend researchers later named the Angelina Jolie effect. Among commercially insured women, daily BRCA testing increased by sixty-four percent in only fifteen business days.
That number translates to about four thousand five hundred additional tests in that short period. Many women who might never have been tested were suddenly able to discover whether they were at risk.
Despite the rise in testing, there was no dramatic increase in unnecessary preventive mastectomies. In some studies, mastectomy rates even dipped slightly among newly tested women, from about ten percent to about seven percent. Many of these women turned out to have a lower risk than they feared.
But for confirmed BRCA carriers, the picture was more defined. Preventive mastectomy reduces their lifetime risk of breast cancer, and some long-term studies show almost no new cancers after the procedure.
Beyond Mastectomy
Even so, preventive mastectomy is not the only option available. There are choices like increased surveillance, alternate surgical approaches, and certain preventive medications. And survival outcomes do not always show a clear advantage for bilateral surgery over more conservative options for every group. The decision is deeply personal and shaped by access, culture, finances, and medical advice.
Nipple sparing mastectomy, with or without a delay step, often gives good cosmetic and functional outcomes. But it still carries risks. There can be changes in sensation. There can be complications such as nipple tissue damage. And the entire treatment process requires time, emotional energy, and financial capacity. Even with insurance, out-of-pocket costs vary from one patient to another.
Angelina Jolie’s recent reflections on her scars tie all of this together. Her story is moving and meaningful. But it also shines a light on the unevenness within the system. She had access to top-level surgeons, advanced techniques, and the freedom to move through her staged treatment without obstacles. Most women do not have that. Many face barriers that are rooted not in lack of courage but in lack of access.